Protein kinase CK2 links extracellular growth factor signaling with the control of p27Kip1 stability in the heart

Nature Medicine

Volumn 14, Issue 3, 2008, Pages 315-324

  Hauck, Ludger ^a,b   Harms, Christoph ^c   Rohne, Jens ^d   Gertz, Karen ^c   Dietz, Rainer ^d,e   Endres, Matthias ^c   Von Harsdorf, Rüdiger ^a,b  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b UNIVERSITY HEALTH NETWORK   (Canada)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d HUMBOLDT UNIVERSITY   (Germany)

^e MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN II; CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE INHIBITOR 1B; CYCLIN E; GROWTH FACTOR; PROTEASOME; PROTEIN KINASE;

ARTICLE; CELL DIFFERENTIATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; FEEDBACK SYSTEM; HEART; HEART HYPERTROPHY; HUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

AGING; ANGIOTENSIN II; ANIMALS; CARDIOMEGALY; CASEIN KINASE II; CELL PROLIFERATION; CELLS, CULTURED; CYCLIN-DEPENDENT KINASE INHIBITOR P27; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; MICE, KNOCKOUT; MYOCARDIUM; MYOCYTES, CARDIAC; PROTEIN BINDING; RATS; SIGNAL TRANSDUCTION;

EID: 40449122286     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm1729     Document Type: Article

References (50)

1. Berthet, C. & Kaldis, P. Cell-specific responses to loss of cyclin-dependent kinases. Oncogene 26, 4469-4477 (2007).
2. Koff, A., Ohtsuki, M., Polyak, K., Roberts, J.M. & Massagué, J. Negative regulation of G1 in mammalian cells: inhibition of cyclin E-dependent kinase by TGF-β. Science 260, 536-539 (1993).
3. Hengst, L., Dulic, V., Slingerland, J.M., Lees, E. & Reed, S.I. A cell cycle-regulated inhibitor of cyclin-dependent kinases. Proc. Natl. Acad. Sci. USA 91, 5291-5295 (1994).
4. Kip1) of cyclin-dependent kinase 4 activation. Cell 79, 487-496 (1994).
5. Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 78, 59-66 (1994).
6. Toyoshima, H. & Hunter, T. p27, a novel inhibitor of G1 cyclin-CDK protein kinase activity, is related to p21. Cell 78, 67-74 (1994).
7. Pagano, M. et al. Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. Science 269, 682-685 (1995).
8. Kip1 accumulation during the cell cycle. Science 271, 1861-1864 (1996).
9. Tomoda, K., Kubota, Y. & Kato, J. Degradation of the cyclin-dependent- kinase inhibitor p27Kip1 is instigated by Jab1. Nature 398, 160-165 (1999).
10. Hara, T. et al. Degradation of p27(Kip1) at the G0-G1 transition mediated by a Skp2-independent ubiquitination pathway. J. Biol. Chem. 276, 48937-48943 (2001).
11. Kip1 at G1 phase. Nat. Cell Biol. 6, 1229-1235 (2004).
12. Kotoshiba, S., Kamura, T., Hara, T., Ishida, N. & Nakayama, K.I. Molecular dissection of the interaction between p27 and KPC, the ubiquitin ligase that regulates proteolysis of p27 in G1 phase. J. Biol. Chem. 280, 17694-17700 (2005).
13. Kip1 on serine 10 is required for its binding to CRM1 and nuclear export. J. Biol. Chem. 277, 14355-14358 (2002).
14. Kotake, Y., Nakayama, K., Ishida, N. & Nakayama, K.I. Role of serine 10 phosphorylation in p27 stabilization revealed by analysis of p27 knock-in mice harboring a serine 10 mutation. J. Biol. Chem. 280, 1095-1102 (2005).
15. Kip1 stability, subcellular localization, and tumor suppression. Genes Dev. 20, 47-64 (2006).
16. Rodier, G. et al. p27 cytoplasmic localization is regulated by phosphorylation on Ser10 and is not a prerequisite for its proteolysis. EMBO J. 20, 6672-6682 (2001).
17. LaBaer, J. et al. New functional activities for the p21 family of CDK inhibitors. Genes Dev. 11, 847-862 (1997).
18. Kip1. Genes Dev. 11, 1464-1478 (1997).
19. Carrano, A.C., Eytan, E., Hershko, A. & Pagano, M. SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27. Nat. Cell Biol. 1, 193-199 (1999).
20. Montagnoli, A. et al. Ubiquitination of p27 is regulated by Cdk-dependent phosphorylation and trimeric complex formation. Genes Dev. 13, 1181-1189 (1999).
21. Nakayama, K. et al. Skp2-mediated degradation of p27 regulates progression into mitosis. Dev. Cell 6, 661-672 (2004).
22. Aleem, E., Kiyokawa, H. & Kaldis, P. Cdc2-cyclin E complexes regulate the G1/S phase transition. Nat. Cell Biol. 7, 831-836 (2005).
23. Kip1 in G1 and S phase. Nature 413, 323-327 (2001).
24. Kip1-deficient mice. Cell 85, 733-744 (1996).
25. Kip1. Cell 85, 721-732 (1996).
26. Kip1 display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors. Cell 85, 707-720 (1996).
27. Loda, M. et al. Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas. Nat. Med. 3, 231-234 (1997).
28. Liang, J. et al. PKB/Akt phosphorylates p27, impairs nuclear import of p27 and opposes p27-mediated G1 arrest. Nat. Med. 8, 1153-1160 (2002).
29. Kip1 at threonine 157 and modulation of its cellular localization. Nat. Med. 8, 1145-1152 (2002).
30. Kip1 by PKB/Akt-mediated phosphorylation in breast cancer. Nat. Med. 8, 1136-1144 (2002).
31. Pasumarthi, K.B.S. & Field, L.F. Cardiomyocyte cell cycle regulation. Circ. Res. 90, 1044-1054 (2002).
32. Burton, P.B., Yacoub, M.H. & Barton, P.J. Cyclin-dependent kinase inhibitor expression in human heart failure. A comparison with fetal development. Eur. Heart J. 20, 604-611 (1999).
33. Kip1 knockout mice. Circ. Res. 85, 117-127 (1999).
34. Sadoshima, J., Xu, Y., Slayter, H.S. & Izumo, S. Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vitro. Cell 75, 977-984 (1993).
35. Chien, K.R. & Olson, E.N. Converging pathways and principles in heart development and disease. Cell 110, 153-162 (2002).
36. Litchfield, D.W. Protein kinase CK2: structure, regulation and role in cellular decisions of life and death. Biochem. J. 369, 1-15 (2003).
37. Meggio, F. & Pinna, L.A. One-thousand-and-one substrates of protein kinase CK2? FASEB J. 17, 349-368 (2003).
38. Cip1. Nature 375, 159-161 (1995).
39. Kip1 are directly regulated by oncogenic tyrosine kinases. Cell 128, 269-280 (2007).
40. Chu, I. et al. p27 phosphorylation by Src regulates inhibition of cyclin E-Cdk2. Cell 128, 281-294 (2007).
41. Kip1 induces cell migration. Nat. Med. 4, 1449-1452 (1998).
42. Hunter, J.J. & Chien, K.R. Signaling pathways for cardiac hypertrophy and failure. N. Engl. J. Med. 341, 1276-1283 (1999).
43. Hirota, H. et al. Loss of a gp130 cardiac muscle cell survival pathway is a critical event in the onset of heart failure during biomechanical stress. Cell 97, 189-198 (1999).
44. Satoh, M. et al. Requirement of Rac1 in the development of cardiac hypertrophy. Proc. Natl. Acad. Sci. USA 103, 7432-7437 (2006).
45. Li, P.F. et al. Phosphorylation by protein kinase CK2: a signaling switch for the caspase-inhibiting protein ARC. Mol. Cell 10, 247-258 (2002).
46. Donath, S. et al. Apoptosis repressor with caspase recruitment domain is required for cardioprotection in response to biomechanical and ischemic stress. Circulation 113, 1203-1212 (2006).
47. Seldin, D.C. & Leder, P. Casein kinase IIα transgene-induced murine lymphoma: relation to theileriosis in cattle. Science 267, 894-897 (1995).
48. Xu, X., Toselli, P.A., Russell, L.D. & Seldin, D.C. Globozoospermia in mice lacking the casein kinase IIα′ catalytic subunit. Nat. Genet. 23, 118-121 (1999).
49. Kato, T. Jr, Delhase,M., Hoffmann, A. & Karin, M. CK2 is a C-terminal IκB kinase responsible for NF-κB activation during the UV response. Mol. Cell 12, 829-839 (2003).
50. Scaglioni, P.P. et al. A CK2-dependent mechanism for degradation of the PML tumor suppressor. Cell 126, 269-283 (2006).